Funding Tracker/Contego Medical
Planned acquisition · Cardiovascular · United States
Contego Medical: $380M acquisition agreement
Announced November 16, 2026
The round
Contego Medical announced a Planned acquisition with approximately $380M enterprise value on November 16, 2026.
The SignalMedtronic announced its intent to acquire Contego Medical for $380 million plus potential payments. Expected closing in its fiscal third quarter is subject to customary conditions. This is an announced transaction, not a completed acquisition.
What Contego Medical does
Integrated embolic protection and thrombectomy devices for vascular procedures.
Contego Medical develops carotid and peripheral vascular devices, including Neuroguard IEP and Excipio. Ravish Sachar, MD, and Jay Yadav, MD, founded the company. On 16 November 2026, Medtronic announced its intent to acquire Contego for $380 million plus potential payments, with closing expected in Medtronic's fiscal third quarter. Neuroguard IEP Direct received FDA PMA approval, with 510(k) clearance for its embolic protection system announced on 10 November. The company reported 0% 30-day stroke in the PERFORMANCE III intention-to-treat population and a 0.69% major adverse event rate; these are study-specific results.
Full Contego Medical profile- Company
- Contego Medical
- Enterprise value
- $380M
- Stage
- Planned acquisition
- Announced
- November 16, 2026
- Led by
- Not disclosed
- Vertical
- Cardiovascular
- Country
- United States
- Headquarters
- Raleigh, NC, United States